Accéder au contenu
Merck
Toutes les photos(1)

Principaux documents

Voir toute la documentation

Y0000683

Phenylephrine hydrochloride for peak identification

European Pharmacopoeia (EP) Reference Standard

Synonyme(s) :

(R)-(−)-Phenylephrine hydrochloride, (R)-(−)-1-(3-Hydroxyphenyl)-2-methylaminoethanol hydrochloride, (R)-(−)-3-Hydroxy-α-(methylaminomethyl)benzyl alcohol hydrochloride

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Formule linéaire :
HOC6H4CH(CH2NHCH3)OH·HCl
Numéro CAS:
61-76-7
Poids moléculaire :
203.67
Beilstein:
4158948
Numéro MDL:
MFCD00012605
Code UNSPSC :
41116107
ID de substance PubChem :
329831094
Nomenclature NACRES :
NA.24

Qualité

pharmaceutical primary standard

Famille d'API

phenylephrine

Fabricant/nom de marque

EDQM

Pf

143-145 °C (lit.)

Application(s)

pharmaceutical (small molecule)

Format

neat

Température de stockage

2-8°C

Chaîne SMILES 

OC1=CC([C@H](CNC)O)=CC=C1.Cl

InChI

1S/C9H13NO2.ClH/c1-10-6-9(12)7-3-2-4-8(11)5-7;/h2-5,9-12H,6H2,1H3;1H/t9-;/m0./s1

Clé InChI

OCYSGIYOVXAGKQ-FVGYRXGTSA-N

Informations sur le gène

human ... ADRA1A(148) , ADRA1B(147) , ADRA1D(146)

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Description générale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Phenylephrine hydrochloride for peak identification EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Conditionnement

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Autres remarques

Sales restrictions may apply.

Produit(s) apparenté(s)

Réf. du produit
Description
Tarif

PHR1017

Phenylephrine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material

P1240000

Phenylephrine, European Pharmacopoeia (EP) Reference Standard

P1250000

Phenylephrine hydrochloride, European Pharmacopoeia (EP) Reference Standard

1533002

Phenylephrine hydrochloride, United States Pharmacopeia (USP) Reference Standard

PHR1695

Phenylephrine Related Compound C, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1712

Phenylephrine Related Compound E, Pharmaceutical Secondary Standard; Certified Reference Material

1533046

Phenylephrine Related Compound E, United States Pharmacopeia (USP) Reference Standard

1533035

Phenylephrine Related Compound D, United States Pharmacopeia (USP) Reference Standard

1532950

Phenylephrine bitartrate, United States Pharmacopeia (USP) Reference Standard

1533024

Phenylephrine Related Compound C, United States Pharmacopeia (USP) Reference Standard

1533261

Phenylephrine Related Compound F, United States Pharmacopeia (USP) Reference Standard

1533272

Phenylephrine Related Compound G, United States Pharmacopeia (USP) Reference Standard

BP284

Phenylephrine hydrochloride, British Pharmacopoeia (BP) Reference Standard

PHR2153

2-Hydroxy-N-[(2R)-2-hydroxy-2-(3-hydroxyphenyl)ethyl]-N-methylacetamide, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2151

1,2,3,4-Tetrahydro-4,6-dihydroxy-2-methylisoquinoline hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2148

Phenylephrine Related Compound D, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2154

N-Formylphenylephrine, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2149

Phenylephrine Related Compound F, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2150

Phenylephrine Related Compound G, Pharmaceutical Secondary Standard; Certified Reference Material

PHR3221

Phenylephrine Bitartrate, pharmaceutical secondary standard, certified reference material

Pictogrammes

Exclamation mark
GHS07

Mention d'avertissement

Warning

Mentions de danger

H302,H317

Classification des risques

Acute Tox. 4 Oral - Skin Sens. 1B

Code de la classe de stockage

11 - Combustible Solids

Classe de danger pour l'eau (WGK)

WGK 1

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable

Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number

Désolés, nous n'avons pas de COA pour ce produit disponible en ligne pour le moment.

Si vous avez besoin d'assistance, veuillez contacter Service Clients

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Les clients ont également consulté

Slide 1 of 6

1 of 6

USP

USP

1533035

Phenylephrine Related Compound D

vibrant-m

Y0001170

Ascorbic acid impurity D

Diclofenac for system suitability European Pharmacopoeia (EP) Reference Standard

Y0001635

Diclofenac for system suitability

Paracetamol impurity J European Pharmacopoeia (EP) Reference Standard

Y0001945

Paracetamol impurity J

4-Aminophénol European Pharmacopoeia (EP) Reference Standard

Y0001955

4-Aminophénol

Méthylparaben Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1012

Méthylparaben

C A Boly et al.
British journal of anaesthesia, 111(5), 750-758 (2013-07-11)
Left-ventricular end-systolic elastance (Ees) is an index of cardiac contractility, but the invasive nature of its assessment has limited perioperative application. We explored the feasibility of a minimally invasive method of Ees estimation for perioperative assessment of cardiac function and
Doreen Schmidl et al.
Investigative ophthalmology & visual science, 54(3), 1964-1970 (2013-02-27)
We determined whether administration of a nitric oxide synthase (NOS) inhibitor alters optic nerve head blood flow (ONHBF) regulation during isometric exercise in healthy subjects. Our study was done in a randomized, placebo-controlled, double-masked, three-way crossover design. A total of
Dale A Currigan et al.
Anesthesiology, 121(5), 930-936 (2014-09-10)
Vasopressor drugs, commonly used to treat systemic hypotension and maintain organ perfusion, may also induce regional vasoconstriction in specialized vascular beds such as the lung. An increase in pulmonary vascular tone may adversely affect patients with pulmonary hypertension or right
Heather Mak et al.
Ophthalmology, 120(12), 2517-2524 (2013-07-16)
To measure iris volume and anterior segment parameters using a swept-source anterior segment optical coherence tomography (OCT) and investigate factors associated with iris volume and iris volume change after pupil dilation in eyes with open angles and angle closure. Cross-sectional
Stephanie W Watts et al.
Arteriosclerosis, thrombosis, and vascular biology, 33(6), 1320-1328 (2013-04-06)
Obesity and hypertension are comorbid in epidemic proportion, yet their biological connection is largely a mystery. The peptide chemerin is a candidate for connecting fat deposits around the blood vessel (perivascular adipose tissue) to arterial contraction. We presently tested the
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique